Jamin A. Willoughby - Concepedia

Author

Jamin A. Willoughby

Cyprotex (United States)

Also Known As

J. A. Willoughby, J. Willoughby, J.A. Willoughby, J.A.S. Willoughby, Jamin A. Willoughby, Jamin Willoughby

Publications

813

Citations

H-Index

Concepts

All Affiliations

Cyprotex (United States)MatTek (Slovakia)Envigo (United Kingdom)Flemish Institute for Technological Research L'Oréal (France)

About

Jamin A. Willoughby is an author at Cyprotex (United States) specializing in medicine, toxicology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	446
2	Allergy	5	5	95
3	Engineering	3	3	119
4	Public Health	2	2	37
5	Biomedical Engineering	2	2	102

Jamin A. Willoughby

Publications

690

Citations

H-Index

Page 1

	Year	Citations
Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression Jamin A. Willoughby, Shyam N. Sundar, Mark Cheung, Journal of Biological Chemistry	2008	165
Effects of carrageenan on cell permeability, cytotoxicity, and cytokine gene expression in human intestinal and hepatic cell lines James M. McKim, Heidi Baas, Gabriel P. Rice, Food and Chemical Toxicology ImmunotoxicologyGastrointestinal PharmacologyImmune RegulationGastroenterologyPathology	2016	96
Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells Shyam N. Sundar, Crystal N. Marconett, Victor B. Doan, Carcinogenesis	2008	60
Pre-validation of an in vitro skin irritation test for medical devices using the reconstructed human tissue model EpiDerm™ Helena Kanďárová, Jamin A. Willoughby, Wim H. de Jong, Toxicology in Vitro Tissue EngineeringEngineeringBiomedical EngineeringDermatologySkin Irritation Potential	2018	55
Round robin study to evaluate the reconstructed human epidermis (RhE) model as an in vitro skin irritation test for detection of irritant activity in medical device extracts Wim H. de Jong, Sebastian Hoffmann, Michelle Lee, Toxicology in Vitro EngineeringBiomedical EngineeringDermatologyMedical Device ExtractsSesame Oil	2018	47
In vitro human skin irritation test for evaluation of medical device extracts J. Casas, Gregory M. Lewerenz, E.A. Rankin, Toxicology in Vitro MedicineBioanalysisMedical Device ExtractsTopical DrugSkin Allergy	2013	45
Predicting Respiratory Toxicity Using a Human 3D Airway (EpiAirway™) Model Combined with Multiple Parametric Analysis Jamin A. Willoughby Applied In Vitro Toxicology AsthmaAcute Lung InjuryLung InflammationOxidative StressMultiple Parametric Analysis	2015	24
Infantile myoclonic seizures:An evaluation of ACTH and corticosteroid therapy Jamin A. Willoughby, Donald L. Thurston, Jean Holowach The Journal of Pediatrics Neurological DisorderPediatricsMotor DisorderNeurologyCentral Nervous System	1966	23
Artemisinin disrupts androgen responsiveness of human prostate cancer cells by stimulating the 26S proteasome-mediated degradation of the androgen receptor protein Andrea M. Steely, Jamin A. Willoughby, Shyam Sundar, Anti-Cancer Drugs Artemisinin DisruptsAndrogen ReceptorUrologyAndrogen Receptor ProteinChemoprevention Strategy	2017	23
CON4EI: Bovine Corneal Opacity and Permeability (BCOP) test for hazard identification and labelling of eye irritating chemicals Sandra Verstraelen, Gareth Maglennon, Karen Hollanders, Toxicology in Vitro Hazard IdentificationOphthalmologyExperimental OphthalmologyToxicologyBovine Corneal Opacity	2017	22

Page 1